Table 1.
Typical intramuscular high energy phosphate levels in young and old
| Variable | Young (baseline)† | % increase following supplementation‡ | Old (baseline)† | % increase following supplementation‡ |
|---|---|---|---|---|
| Total creatine | 124.6 ± 2.7 (n = 96) [65-68] |
21.7% (n = 36) [66-68] |
129.8 ± 4.0 (n = 109) [20,25,30,31,42] |
14.9% (n = 28) [20,25] |
| Phosphocreatine | 78.2 ± 2.3 (n = 96) [65-68] |
13.3% (n = 36) [66-68] |
78.4 ± 4.1 (n = 109) [20,25,30,31,42] |
8.2% (n = 28) [20,25] |
| Creatine | 46.0 ± 2.3 (n = 96) [65-68] |
39.3% (n = 36) [66-68] |
51.4 ± 3.8 (n = 109) [20,25,30,31,42] |
28.6% (n = 28) [20,25] |
| ATP | 24.0 ± 0.6 (n = 96) [65-68] |
4.2% (n = 36) [66-68] |
20.0 ± 0.6 (n = 91) [20,25,30,31] |
6.8% (n = 28) [20,25] |
Values have been averaged from various investigations and are presented as: mean ± pooled S.E. values (n-size). References are presented as numbers next to value in brackets. Note that all studies assayed for the abovementioned metabolites (opposed to quantitation using 31P nuclear magnetic resonance spectroscopy) and these values are therefore expressed as mmol/kg muscle in dry weight.
† Younger participants were between the ages of 18-36 years old, whereas older participants were between the ages of 52-79 years old.
‡ All of the referenced interventions supplemented subjects either through a loading phase (i.e., 20 g/d for 5 days) or through a 14-to-24 week supplementation protocol using 5 g/d.